SCHEMBL2408100

SCHEMBL2408100

Oc1ccc(-n2cnc3cnc(N4CCCCC4)nc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA3 P51812 2/20 0.47
▸ PIM1 P11309 1/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ ALDH1A1 P00352 8/20 0.39
▸ CYP1A2 P05177 8/20 0.39
▸ HSD17B10 Q99714 7/20 0.39
▸ CASP1 P29466 5/20 0.39
▸ CASP7 P55210 5/20 0.39
▸ USP2 O75604 4/20 0.39
▸ ESR1 P03372 4/20 0.38
▸ ESR2 Q92731 4/20 0.38
▸ HPGD P15428 2/20 0.38
▸ POLB P06746 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NT5E P21589 1/20 0.37
▸ CLK4 Q9HAZ1 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2408379 0.99 RPS6KA3 (0.48) RPS6KA3PIM1FGFR1ALDH1A1CYP1A2
SCHEMBL2407473 0.87 ALDH1A1 (0.54) RPS6KA3ALDH1A1CYP1A2HSD17B10CASP1
SCHEMBL2411816 0.87 RPS6KA3 (0.55) RPS6KA3ALDH1A1CYP1A2HSD17B10CASP1
SCHEMBL22411573 0.85 RPS6KA3 (0.44) RPS6KA3FGFR1ALDH1A1CYP1A2HSD17B10
SCHEMBL2406067 0.84 JAK3 (0.45) RPS6KA3FGFR1ALDH1A1CYP1A2HSD17B10
SCHEMBL2410911 0.84 CFTR (0.45) RPS6KA3FGFR1ALDH1A1CYP1A2HSD17B10
SCHEMBL2409783 0.83 RPS6KA3 (0.43) RPS6KA3ALDH1A1CYP1A2HSD17B10CASP1
SCHEMBL2409354 0.83 ESR1 (0.44) RPS6KA3ALDH1A1CYP1A2HSD17B10CASP1
SCHEMBL2407291 0.83 CFTR (0.46) RPS6KA3FGFR1ALDH1A1CYP1A2HSD17B10
SCHEMBL2407675 0.82 ESR1 (0.45) RPS6KA3ALDH1A1CYP1A2HSD17B10CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO claimed
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO disclosed
WO-2011106168-A1 PURINE COMPOUNDS FOR TREATING AUTOIMMUNE AND DEMYELINATING DISEASES DCAM PHARMA INC (US) 2011-09-01 — — WO disclosed
Send feedback